Schematic illustration of experimental procedure and comparison by Akinaka Morii (12709672)

Subjects:

Stacked bar plots illustrating the relative abundance distribution of fecal microbial communities in thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

Characteristics and outcomes of participants categorized by serum APTT on admission. by Huan Wang (109286)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Parameter estimates from the final models for <i>M</i>. <i>mercenaria</i> & <i>M</i>. <i>arenaria</i> mortality. by Teagan McMahon (20108036)

Subjects:

Effects of allopurinol on PG-LPS-induced phospho-CaMKII by Akinaka Morii (12709672)

Subjects:

Microscopic morphology of different asphalts (200 × , 1000 × , and 1500×). by Yi Wang (32470)

Subjects:

Schematic diagram of the experimental workflow. by Bhuripit Saraphol (20855573)

Subjects:

Digital Microfluidic Platform Based on Printed Circuit Board for Affinity Evaluation of Mertansine Aptamers by Dongliu Xiang (10688647)

Subjects:

Unmatched kernel density function diagram. by Yanling Li (269030)

Subjects:

Normality test using the Shapiro-Wilk test. by Akinaka Morii (12709672)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

a) ECM components and collagen structure change with tumor progression, which influences cancer cell proliferation and metastasis. b) SHG visual representation of collagen patterns... by Zoë Dinkel (21402766)

Subjects:

Image 3_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Image 1_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Image 2_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Image 4_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”